Rheostat Therapeutics
Rheostat, located at 300 Technology Square, in Cambridge, Massachusetts is a biotech company developing treatments for neurodegenerative diseases by targeting mitophagy and autophagy pathways.
2
Funding Rounds
$46.0m
Money raised
Overview
Rheostat, located at 300 Technology Square, in Cambridge, Massachusetts is a biotech company developing treatments for neurodegenerative diseases by targeting mitophagy and autophagy pathways.
- Website:
- Business model: B2B
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Rheostat Therapeutics has raised a total of $23m in funding over 2 rounds.
Key Insights:
- Rheostat Therapeutics Series A round, November 2018: $23m
- Rheostat Therapeutics funding round, November 2018: $23m
Rheostat Therapeutics Series A round, November 2018
$23m
Rheostat Therapeutics funding round, November 2018
$23m
Industries
Rheostat Therapeutics is active in the following industries: